Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case seriesMarc Scherlinger, Emmanuel Chatelus, Roberto D’Alessandro et al.|Annals of the Rheumatic Diseases|2026Cited by 5
OC.53 Use of the CD19/CD3 T cell engager blinatumomab in refractory systemic sclerosis: a case seriesJerome Avouac, Yannick Allanore, Marc Scherlinger et al.|Unknown|2026Cited by 0